Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN Cause Maternal exposure timing unspecified? 111 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Maternal exposure timing unspecified have been filed in association with NAPROXEN (Naproxen Sodium). This represents 0.2% of all adverse event reports for NAPROXEN.

111
Reports of Maternal exposure timing unspecified with NAPROXEN
0.2%
of all NAPROXEN reports
100
Deaths
105
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From NAPROXEN?

Of the 111 reports, 100 (90.1%) resulted in death, 105 (94.6%) required hospitalization, and 107 (96.4%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN. However, 111 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN Cause?

Drug ineffective (12,416) Product use issue (4,865) Off label use (4,434) Drug hypersensitivity (4,160) Pain (4,140) Nausea (4,139) Vomiting (3,889) Fatigue (3,659) Diarrhoea (3,498) Dizziness (3,460)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which NAPROXEN Alternatives Have Lower Maternal exposure timing unspecified Risk?

NAPROXEN vs NAPROXEN\NAPROXEN NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN vs NARATRIPTAN NAPROXEN vs NASONEX

Related Pages

NAPROXEN Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified NAPROXEN Demographics